Cargando…
Everything Old Is New Again: Drug Repurposing Approach for Non-Small Cell Lung Cancer Targeting MAPK Signaling Pathway
Non-small cell lung cancer (NSCLC) is a prominent subtype of lung carcinoma that accounts for the majority of cancer-related deaths globally, and it is responsible for about 80% to 85% of lung cancers. Mitogen-Activated Protein Kinase (MAPK) signaling pathways are a vital aspect of NSCLC, and have a...
Autores principales: | Jain, Anisha S., Prasad, Ashwini, Pradeep, Sushma, Dharmashekar, Chandan, Achar, Raghu Ram, Silina, Ekaterina, Stupin, Victor, Amachawadi, Raghavendra G., Prasad, Shashanka K., Pruthvish, R, Syed, Asad, Shivamallu, Chandan, Kollur, Shiva Prasad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526962/ https://www.ncbi.nlm.nih.gov/pubmed/34692523 http://dx.doi.org/10.3389/fonc.2021.741326 |
Ejemplares similares
-
Corrigendum: Everything Old Is New Again: Drug Repurposing Approach for Non-Small Cell Lung Cancer Targeting MAPK Signaling Pathway
por: Jain, Anisha S., et al.
Publicado: (2021) -
In silico evaluation of flavonoids as effective antiviral agents on the spike glycoprotein of SARS-CoV-2
por: Jain, Anisha S., et al.
Publicado: (2021) -
Genistein: A Potent Anti-Breast Cancer Agent
por: Bhat, Smitha S., et al.
Publicado: (2021) -
Alzheimer’s Disease and Herbal Combination Therapy: A Comprehensive Review
por: Pradeep, Sushma, et al.
Publicado: (2020) -
Cell cycle arrest and apoptotic studies of Terminalia chebula against MCF-7 breast cancer cell line: an in vitro and in silico approach
por: Reddy, Pruthvish, et al.
Publicado: (2023)